SelectEvidence®
from Nova Leah
SelectEvidence® from Nova Leah automates cybersecurity risk management for connected medical devices.
-
Detailed product demo.
-
No credit card required. No strings.
-
Obligation free walk-through.
-
Free five day evaluation available.

Awards
Technology Ireland Awards | Ibec
Emerging Company of the Year -2019
High Potential Exporter Award
Export Industry Awards Winner 2019
KTI Impact Awards 2019
Spin-out Company Award Winner 2019
Centralized cybersecurity risk management
SelectEvidence® from Nova Leah allows manufacturers of connected medical devices to automate the process of conducting premarket and postmarket cybersecurity risk assessments for entire product portfolios.
SelectEvidence® breakdown:
- Risk assessment platform.
- sBoM ingestion.
- Continuous vulnerability monitoring.
- Automated MDF2 generation.
- Risk analysis decision support.
- Threat modelling.
- FDA premarket and postmarket cybersecurity compliance.

“A specialist in cybersecurity for medical devices”
“A specialist in cybersecurity for medical devices, its platform SelectEvidence® helps medical device providers to monitor defibrillators, pacemakers and insulin pumps connected to wireless networks, to ensure they are safe and can deal with potential threats.”
WIRED Magazine, Listing Europe’s 100 Hottest Startups 2019

Simple and straightforward trial process

30 minute product demo
Detailed run-through
We provide all prospective users with a detailed product demo. We demonstrate how SelectEvidence® saves time and automates cybersecurity risk management.

Free five-day evaluation
Mapped to your own success criteria
Demos are followed by a free, five-day evaluation where MDMs discover how SelectEvidence® integrates seamlessly into their product development lifecycle.

Connect and review
Outlining clear integration pathways
Upon successful completion of the first two stages, we reconnect with all stakeholders and decision-makers to put a clear integration plan in place.
Ready to get started?
Request a free demo to see how SelectEvidence® helps effortlessly integrate
cybersecurity processes into your system development life cycle.
Leadership team

Anita Finnegan
CEO/Founder
Anita founded Nova Leah and is the Author and International Project Leader of IEC 80001-2-8 and IEC 80001-2-9. As an internationally recognized expert in Medical Device Cybersecurity she also has a strong background in software quality processes, engineering and quality engineering roles across multiple highly regulated domains. Anita’s PhD research focused on medical device cybersecurity assurance cases.

Peter Finnegan
Co-Founder
Peter brings over 30 years’ experience in the global healthcare and pharmaceutical business to Nova Leah. Peters expertise culminated over 28 years of senior management leadership.

Fergal McCaffery
Co-founder / Head of Engineering
Fergal is internationally recognized for his contributions to medical device software engineering. His research team have led the development of 4 International Standards/Technical reports for medical device software. He was also the Leader for the development of IEC/TR 80002-3 for medical device software processes in collaboration with the ISO/IEC 62304 development team. Fergal is also Senior Lecturer in the Department of Computing and Mathematics, in Dundalk Institute of Technology (DkIT).
Request your free demo
One of our team will be in touch, to schedule your demo of SelectEvidence the award winning software from Nova Leah.